Drupal.behaviors.print = function(context) {window.print();window.close();}>

Rosetta Regains US Rights to miRNA Cancer Diagnostics, Addresses QC Issue at Diagnostics Lab

December 02, 2010

Rosetta Regains US Rights to miRNA Cancer Diagnostics, Addresses QC Issue at Diagnostics Lab

The company also reported its third-quarter financial results, posting a rise in losses amid higher expenses.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.

Related Stories